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Background
Human phosphoglycerate dehydrogenase (PHGDH), the
first enzyme in the serine biosynthetic pathway, is genomi-
cally amplified in various tumors [1-3]. In such cells,
PHGDH knockdown is not fully rescued by exogenous
serine [2], suggesting possible additional roles for the
enzyme.
Materials and methods
To analyze the catalytic activity of PHGDH on possible
alternative substrates, we conducted in vitro biochemical
assays on recombinant human PHGDH. The reaction rate
in the reductive direction with various substrates was
monitored based on NADH consumption, measured by
absorbance at 340 nm. The identity and chirality of
products were analyzed by liquid chromatography-mass
spectrometry (LC-MS) and by gas chromatography-mass
spectrometry (GC-MS) after (R)-2-butanol derivatization.
To analyze the intracellular function of PHGDH, we
generated stable PHGDH knockdown cell lines, using two
shRNA sequences. Metabolite levels in the knockdown
cells were analyzed by LC-MS [4], and DNA and histone
methylation was analyzed by immunoblotting.
Results
Here we show that, in addition to catalyzing oxidation of
3-phosphoglycerate, PHGDH catalyzes NADH-dependent
reduction of a-ketoglutarate to the oncometabolite
D-2-hydroxyglutarate (D-2HG) and promotes histone
methylation. The impact of PHGDH knockdown was
studied in three cell lines with amplified PHGDH: MDA-
MB-468, BT-20, and HCC70. Knockdown of PHGDH
decreased 2HG levels in MDA-MB-468 and BT-20 cells,
but not HCC70 cells (which had the highest 2HG levels of
the three tested cell lines, with levels in MDA-MB-468
and BT-20 cells far below those found in cells with mutant
IDH). These results suggest that PHGDH contributes to
physiological 2HG pools, but may not produce high
enough concentrations to cause pathology. Interestingly,
in all three cell lines, PHGDH knockdown substantially
decreased histone methylation. The mechanism underly-
ing the decreased methylation upon PHGDH knockdown
remains unclear, but it could be restored in MDA-MB-468
and BT-20 cells by addition of D-2HG ester.
Conclusion
PHGDH may promote histone methylation by mechan-
isms including 2-HG production.
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